Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.8 SEK | -0.56% |
|
-4.29% | -48.46% |
May. 15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
Sales 2024 * | 154M 14.51M | Sales 2025 * | 189M 17.89M | Capitalization | 1.76B 167M |
---|---|---|---|---|---|
Net income 2024 * | 40M 3.78M | Net income 2025 * | 49M 4.63M | EV / Sales 2024 * | 10.8 x |
Net cash position 2024 * | 108M 10.23M | Net cash position 2025 * | 128M 12.09M | EV / Sales 2025 * | 8.64 x |
P/E ratio 2024 * |
43.6
x | P/E ratio 2025 * |
36.7
x | Employees | 36 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
1 day | +1.11% | ||
1 week | -2.68% | ||
Current month | -4.22% | ||
1 month | -27.53% | ||
3 months | -23.56% | ||
6 months | -47.29% | ||
Current year | -47.60% |
![Extreme 26.75](/images/extremecours_fleche.png)
![Extreme 26.75](/images/extremecours_fleche.png)
![Extreme 25.65](/images/extremecours_fleche.png)
![Extreme 25.65](/images/extremecours_fleche.png)
![Extreme 25.65](/images/extremecours_fleche.png)
![Extreme 15.65](/images/extremecours_fleche.png)
![Extreme 1.26](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Fredrik Olsson
CEO | Chief Executive Officer | 53 | 01-12-31 |
Magnus Långberg
DFI | Director of Finance/CFO | 53 | 21-12-31 |
Rolf Lood
CTO | Chief Tech/Sci/R&D Officer | 40 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 20-05-04 | |
Director/Board Member | 63 | 18-12-31 | |
Mikael Lönn
BRD | Director/Board Member | 75 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 26.8 | -0.56% | 41 278 |
24-07-02 | 26.95 | -2.71% | 28,710 |
24-07-01 | 27.7 | -2.64% | 49,509 |
24-06-28 | 28.45 | -1.39% | 36,120 |
24-06-27 | 28.85 | +3.04% | 74,333 |
Delayed Quote Nasdaq Stockholm, July 03, 2024 at 03:00 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.60% | 166M | |
-10.98% | 11.38B | |
-19.13% | 6.83B | |
+26.61% | 5.44B | |
+5.19% | 5.52B | |
-20.49% | 3.62B | |
+6.88% | 2.56B | |
-66.28% | 2.26B | |
-11.81% | 2.13B | |
+29.36% | 2.24B |
- Stock Market
- Equities
- GENO Stock